Notícias

BEIJING, AUGUST 24, 2021 - Lepu Medical Technology (Beijing) Co., Ltd. (“Lepu Medical”), a leading global company specialized in developing, manufacturing and marketing high-tech medical devices and equipment, today announced that its Seringa estéril para a linha do Único-uso Ganhou a aprovação da marca CE para uso geral, incluindo a entrega de várias vacinas COVID-19.

A marca CE indica que a seringa estéril para uso único da Lepu Medical atende aos padrões de segurança e desempenho da categoria da União Europeia (UE) para uso por profissionais de saúde para aspiração e injeção de fluidos de uso geral, o que os torna disponíveis para compra profissional em toda a UE e outros países que reconhecem a marca CE.

Lepu Medical’s Seringa estéril para a linha do Único-uso has received CE Mark approval at a time of high-demand for needles suitable to vaccinate populations against the COVID-19 pandemic.  Lepu Medical’s syringe series offers a variety of single-use needles for many applications, including various COVID-19 vaccines. The line includes both Luer Lock and Lock Slip syringes, a clear barrel, plunger, plunger stopper, needle, and cap. Lepu Medical’s syringe series offers a higher resistance to breakage in single-use, and latex-free pistons. The total graduated capacity of all models of syringes is 1mL, with a range of needle sizes to meet a variety of injection and COVID-19 vaccine needs, each distinguished by the color of the needle hub.

Designed to meet a variety of injection needs, Lepu Medical’s Sterile Syringe For Single-Use brings improved safety to patients and doctors with its clear barrel for convenient control of foreign substances. The Sterile Syringe For Single-Use is intended only for one-time use by  healthcare professionals who have received training on medical injection techniques. Injection and vaccine administrators can refer to the Lepu Medical professional manual before use for a full understanding of the device instructions, warnings and precautions.

Além da seringa estéril para uso único, a Lepu Medical forneceu vários suprimentos médicos para COVID-19 prevenção e controle, incluindo o SARS-CoV-2 Antigen Rapid Test Kit para auto-teste e o SARS-CoV-2 Antibody Test Kit para testes profissionais de saúde. A Lepu Medical também oferece soluções de diagnóstico, como produtos e soluções de ácido nucleico para fornecer testes padrão para diagnosticar COVID-19 e produtos de teste de anticorpos para monitorar os níveis de imunidade COVID-19. Outros COVID-19 produtos e soluções da Lepu Medical incluem kits de coleta de amostras, kits manuais de extração, extratores automatizados e sistemas PCR em tempo real para diagnósticos clínicos padrão de ácidos nucleicos.

As of August 2021, the number of global daily doses of COVID-19 vaccines continues to rise, driving demand for vaccines and vaccination supplies. According to published statistics, by the end of 2020, major governments had placed purchases for over nine billion vaccine units. With the onset of the Delta virus, vaccination rates are ramping up and the expected number of vaccine units is increasing. Government officials and medical professionals across the globe from Israel, France, Germany, the U.S, the United Arab Emirates, Bahrain, the United Kingdom, Switzerland, Cambodia and others are proposing and actively preparing for the third dose of the COVID-19 vaccination to strengthen pandemic prevention and control efforts. With the CE Mark approval for the Sterile Syringe For Single-Use, Lepu Medical will continue to proactively seek qualified partners to support the availability of reliable vaccine supplies across the globe, and assist with COVID-19 management and continuation of general medical practices.